ShortageSignal

Scotland · NHS Scotland MSAN

Scotland: medicine supply alerts

NHS Scotland issues its ownMedicine Supply Alert Notices, separate from England's DHSC notifications. This is that record — each notice linked to its signed NHS Scotland PDF. Kept distinct from the England register; the two are never mixed.

360 notices on record to 07 Aug 2026. Source: NHS Scotland (publications.scot.nhs.uk), indexed via Community Pharmacy Scotland.

IssuedMedicineReferenceLevelValid untilSource
07 Aug 2026Diclofenac (Voltarol® Ophtha) 0.1% eye drops 0.3ml unit dose preservative-freeMSAN(2026)26Level 2mid-January 2027PDF ↗
24 Jul 2026Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tabletsMSAN(2026)25Level 2various resupply dates apply. Please see belowPDF ↗
25 Jun 2026Disopyramide (Rythmodan®) 100mg capsules and disopyramide (RythmodanMSAN(2026)20Level 2early April 2027 for Disopyramide (Rythmodan®) 100mg andPDF ↗
24 Jun 2026Propafenone (Arythmol®) 150mg tabletsMSAN(2026)19Level 2late July 2026PDF ↗
12 Jun 2026Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches - UpdateMSAN(2026)18Level 2late September 2026PDF ↗
21 May 2026Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filledMSAN(2026)17Level 2mid-June 2026PDF ↗
07 May 2026Midazolam (Epistatus®) 7.5mg/0.75ml oromucosal solution pre-filled oral syringesMSAN(2026)16Level 2late-May 2026PDF ↗
27 Apr 2026Ramipril 1.25mg capsulesMSAN(2026)15Level 2end of May 2026PDF ↗
22 Apr 2026Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3mlMSAN(2026)14Level 2noted products are being discontinuedPDF ↗
08 Apr 2026Cefixime (Suprax®) 200mg tabletsMSAN(2026)13Level 2mid-October 2026PDF ↗
02 Apr 2026Chlordiazepoxide 5mg and 10mg capsulesMSAN(2026)12Level 2mid-July 2026PDF ↗
06 Mar 2026Co-trimoxazole 40mg/200mg/5ml oral suspension sugar freeMSAN(2026)11Level 2early June 2026PDF ↗
25 Feb 2026Sodium valproate (Epilim Chronosphere®) 100mg modified release granulesMSAN(2026)10Level 2mid-April 2026PDF ↗
25 Feb 2026Propafenone (Arythmol®) 150mg tabletsMSAN(2026)9Level 2early April 2026PDF ↗
18 Feb 2026Phenobarbital 30mg and 60mg tabletsMSAN(2026)8Level 2late March 2026PDF ↗
17 Feb 2026Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-MSAN(2026)7Level 2end of June 2026PDF ↗
13 Feb 2026Sulfadiazine silver (Flamazine®) 1% creamMSAN(2026)6Level 2noted products are being discontinuedPDF ↗
30 Jan 2026Oxybutynin (Kentera®) 3.9mg/24hours transdermal patchesMSAN(2026)5Level 2late-February 2026PDF ↗
16 Jan 2026Buprenorphine/naloxone (Suboxone®) 2mg/500microgram and 8mg/2mgMSAN(2026)4Level 2product has been discontinuedPDF ↗
14 Jan 2026Co-codamol 30mg/500mg tabletsMSAN(2026)3Level 3early June 2026PDF ↗
06 Jan 2026Hypurin® Porcine 30/70 Mix (insulin isophane biphasic porcine) 100units/mlMSAN(2026)2Level 2mid-JanuaryPDF ↗
06 Jan 2026Diamorphine 5mg, 10mg and 100mg powder for solution for injection ampoulesMSAN(2026)1Level 3PDF ↗
30 Dec 2025Pen device for Genotropin® (somatropin) 5.3 mg and 12 mg powder and solventMSAN(2025)58Level 2early 2027PDF ↗
30 Dec 2025Clonidine (Catapres®) 100microgram tabletsMSAN(2025)57Level 2mid-February 2026PDF ↗
24 Dec 2025Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2mlMSAN(2025)56Level 2early February 2026PDF ↗
24 Dec 2025Nifedipine (Adipine® XL) 30mg and 60mg modified-release tabletsMSAN(2025)55Level 2end of January 2026PDF ↗
16 Dec 2025Tresiba® FlexTouch® (insulin degludec) 100units/ml solution for injection 3mlMSAN(2025)54Level 2product has been discontinuedPDF ↗
16 Dec 2025Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-MSAN(2024)53Level 2product has been discontinuedPDF ↗
12 Dec 2025Nifedipine (Fortipine® LA) 40mg modified-release tabletsMSAN(2025)52Level 2TBC - Please refer to medicines supply tool on the SpecialistPDF ↗
09 Dec 2025Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patchesMSAN(2025)51Level 3w/c 22 December 2025PDF ↗
19 Nov 2025Ibandronic acid 150mg tabletsMSAN(2025)50Level 2March 2026PDF ↗
13 Nov 2025Propranolol 80mg and 160mg modified release capsulesMSAN(2025)49Level 2early March 2026PDF ↗
27 Oct 2025Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension forMSAN(2025)48Level 2noted product have been discontinuedPDF ↗
27 Oct 2025Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder andMSAN(2025)47Level 2above noted products are being discontinuedPDF ↗
27 Oct 2025Dalivit® Oral DropsMSAN(2025)46Level 2TBC - Please refer to medicines supply tool on the SpecialistPDF ↗
27 Oct 2025Amiodarone 100mg and 200mg tabletsMSAN(2025)45Level 2w/c 17 November 2025PDF ↗
27 Oct 2025Antimicrobial Agents Used in Tuberculosis (TB) TreatmentMSAN(2025)44Level 3TBC - Please refer to medicines supply tool on the SpecialistPDF ↗
22 Sep 2025Admelog® (insulin lispro) 100units/ml solution for injection 3ml cartridgesMSAN(2025)43Level 2June 2026PDF ↗
28 Aug 2025Repaglinide 500microgram,1mg and 2mg tabletsMSAN(2025)42Level 2early December 2025PDF ↗
25 Aug 2025Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3mlMSAN(2025)41Level 2noted products are being discontinuedPDF ↗
19 Aug 2025Estradiol (Progynova® TS) 50micrograms/24hours and 100micrograms/24hoursMSAN(2025)40Level 2above noted product is being discontinuedPDF ↗
28 Jul 2025Isosorbide mononitrate 10mg tablets (immediate-release)MSAN(2025)39Level 2early September 2025PDF ↗
28 Jul 2025• Hypurin® Porcine Isophane (insulin isophane porcine) 100units/mlMSAN(2025)38Level 2above noted products are being discontinuedPDF ↗
28 Jul 2025• Humulin® I (insulin isophane human) 100units/ml suspension for injectionMSAN(2025)37Level 2above noted products are being discontinuedPDF ↗
18 Jul 2025Abidec® Multivitamin dropsMSAN(2025)36Level 2TBC, further updates on the anticipated resupply date for thisPDF ↗
18 Jul 2025Amiodarone 200mg tabletsMSAN(2025)35Level 2early August 2025PDF ↗
11 Jul 2025Diclofenac (Voltarol® Ophtha) 0.1% eye drops 0.3ml unit dose preservative freeMSAN(2025)34Level 2early October 2025PDF ↗
11 Jul 2025Salbutamol 100micrograms/dose breath actuated inhalers CFC freeMSAN(2025)33Level 2December 2025PDF ↗
08 Jul 2025Betamethasone 500microgram soluble tablets sugar freeMSAN(2025)32Level 2mid-October 2025PDF ↗
25 Jun 2025Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour,MSAN(2025)31Level 2early October 2025PDF ↗
18 Jun 2025Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3mlMSAN(2025)30Level 2noted products are being discontinuedPDF ↗
18 Jun 2025Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension forMSAN(2025)29Level 2noted product is being discontinuedPDF ↗
18 Jun 2025Venlafaxine 37.5mg modified release tabletsMSAN(2025)28Level 2mid-July 2025PDF ↗
06 Jun 2025NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6mlMSAN(2025)27Level 2early 2027PDF ↗
27 May 2025Phenobarbital 15mg/5ml elixirMSAN(2025)26Level 2late June 2025PDF ↗
27 May 2025Tolterodine 2mg and 4mg modified-release capsulesMSAN(2025)25Level 2mid-September 2025PDF ↗
16 May 2025Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hourMSAN(2025)24Level 2early July 2025PDF ↗
16 May 2025Lidocaine (Xylocaine®) 10mg/dose spray sugar freeMSAN(2025)23Level 230 June 2025PDF ↗
07 May 2025Tuberculosis (TB) oral medicinesMSAN(2025)22Level 2various resupply dates – see belowPDF ↗
07 May 2025Diazepam 10mg/2ml solution for injection ampoulesMSAN(2025)21Level 2October 2025PDF ↗
07 May 2025Fentanyl (Effentora®) 200microgram, 400microgram, 600microgram,MSAN(2025)20Level 2various resupply dates – please see information belowPDF ↗
22 Apr 2025Levofloxacin 250mg and 500mg tabletsMSAN(2025)19Level 2late May 2025PDF ↗
22 Apr 2025Fentanyl (Durogesic® DTrans®) 12 micrograms/hour, 25 micrograms/hour,MSAN(2025)18Level 2December 2025PDF ↗
22 Apr 2025Galantamine 8mg, 16mg and 24mg modified-release capsulesMSAN(2025)17Level 2July 2025PDF ↗
11 Apr 2025Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/mlMSAN(2025)16Level 2noted products are being discontinuedPDF ↗
11 Apr 2025Diltiazem (Angitil® SR) 90 mg modified-release capsulesMSAN(2025)15Level 2w/c 28 April 2025PDF ↗
11 Apr 2025Estradiol (Estradot®) 25 micrograms/24 hours, 37.5 micrograms/24 hours, 50MSAN(2025)14Level 2various resupply dates – see belowPDF ↗
26 Mar 2025Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuatedMSAN(2025)11Level 2early April 2025PDF ↗
26 Mar 2025Desmopressin 10microgram/dose nasal sprayMSAN(2025)10Level 2early September 2025PDF ↗
04 Mar 2025Triptorelin acetate (Gonapeptyl® Depot) 3.75mg powder and solvent forMSAN(2025)9Level 2early January 2026PDF ↗
14 Feb 2025Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tabletsMSAN(2025)8Level 2Various dates, please refer to the summary supply table belowPDF ↗
05 Feb 2025Camellia sinensis extract (Catephen®) 10% ointmentMSAN(2025)7Level 2late April 2025PDF ↗
05 Feb 2025Memantine (Valios®) 5mg orodispersible tablets sugar freeMSAN(2025)6Level 2late April 2025PDF ↗
22 Jan 202522 January 2025MSAN(2025)5PDF ↗
16 Jan 2025Zanamivir (Dectova®) 200mg/20ml solution for infusion vialsMSAN(2025)3Level 3late January 2025PDF ↗
11 Jan 2025Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusionMSAN(2025)2Level 2product is being discontinuedPDF ↗
11 Jan 2025NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3mlMSAN(2025)1Level 2product is being discontinuedPDF ↗
27 Dec 2024Prednisolone 20mg/100ml rectal solutionMSAN(2024)70Level 2February 2025PDF ↗
27 Dec 2024Estradiol (Estradot®) 50micrograms/24 hours, 75micrograms/24 hours, andMSAN(2024)69Level 2various resupply dates – see belowPDF ↗
27 Dec 2024Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release)MSAN(2024)68Level 2late February 2025PDF ↗
27 Dec 2024Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar freeMSAN(2024)67Level 2mid-2025PDF ↗
11 Dec 2024Imiquimod (Aldara® 5% and Bascellex® 50mg/g) cream 250mg sachetsMSAN(2024)66Level 2mid-January 2025PDF ↗
11 Dec 2024Diclofenac (Voltarol® Ophtha Multidose) 0.1% eye dropsMSAN(2024)65Level 2mid-March 2025PDF ↗
11 Dec 2024Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampooMSAN(2024)64Level 2product is being discontinued from February 2025.PDF ↗
22 Nov 2024NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3mlMSAN(2024)63Level 2product is being discontinuedPDF ↗
21 Nov 2024Levobunolol (Betagan®) 0.5% eye drops 0.4ml unit dose preservative freeMSAN(2024)62Level 2product is being discontinuedPDF ↗
30 Oct 2024Rifampicin and Isoniazid (Rifinah®) 300mg/150mg tabletsMSAN(2024)61Level 2mid-November 2024PDF ↗
16 Oct 2024Trandate® (labetalol) 50mg tabletsMSAN(2024)60Level 2product to be discontinued from July 2025PDF ↗
16 Oct 2024Artemether 20mg / lumefantrine 120mg (Riamet®) tabletsMSAN(2024)59Level 2mid-November 2024PDF ↗
16 Oct 2024Torasemide 10mg tabletsMSAN(2024)58Level 2March 2025PDF ↗
04 Oct 2024Isosorbide mononitrate 60mg modified-release tablets and capsules - UpdateMSAN(2024)57Level 2various re-supply dates, see belowPDF ↗
24 Sep 2024Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-MSAN(2024)56Level 2end of November 2024PDF ↗
24 Sep 2024Nicorandil 10mg tabletsMSAN(2024)55Level 24th October 2024PDF ↗
20 Sep 2024Trandolapril 2mg and 4mg capsulesMSAN(2024)54Level 2Late December 2024PDF ↗
30 Aug 2024Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit doseMSAN(2024)53Level 2w/c 30th September 2024PDF ↗
28 Aug 2024Isosorbide mononitrate 60mg modified-release tablets and capsulesMSAN(2024)52Level 2various re-supply dates, see belowPDF ↗
28 Aug 2024Creon® Micro Pancreatin 60.12mg gastro-resistant granulesMSAN(2024)51Level 3late September 2024PDF ↗
28 Aug 2024Norethisterone (Noriday®) 350microgram tabletsMSAN(2024)50Level 2early December 2024PDF ↗
28 Aug 2024Naltrexone 50mg tabletsMSAN(2024)49Level 2late October 2024PDF ↗
23 Aug 2024Methylphenidate prolonged-release tabletsMSAN(2024)48Level 3October 2024PDF ↗
09 Aug 2024Cefalexin 500mg tabletsMSAN(2024)47Level 2late September 2024PDF ↗
09 Aug 2024Ramipril 2.5mg tabletsMSAN(2024)46Level 2November 2024PDF ↗
05 Aug 2024Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoulesMSAN(2024)45Level 2w/c 16th SeptemberPDF ↗
24 Jul 2024Quetiapine 150mg, 200mg, 300mg tablets - UPDATEMSAN(2024)43Level 2late August 2024PDF ↗
17 Jul 2024Ipratropium bromide 250micrograms/1ml and 500micrograms/2ml nebuliserMSAN(2024)42Level 2late March 2025PDF ↗
05 Jul 2024Disopyramide (Rythmodan Retard®) 250mg modified-release tablets andMSAN(2024)41Level 2mid-January 2025PDF ↗
28 Jun 2024Disopyramide (Rythmodan Retard®) 250mg modified-release tablets andMSAN(2024)40Level 2mid-January 2025PDF ↗
11 Jun 2024Quetiapine 150mg, 200mg, 300mg tabletsMSAN(2024)35Level 2late August 2024PDF ↗
11 Jun 2024Imiquimod (Aldara®) 5% cream and podophyllotoxin (Warticon®) 0.5% solutionMSAN(2024)34Level 2mid-October 2024PDF ↗
11 Jun 2024Co-trimoxazole 40mg/200mg/5ml oral suspension sugar freeMSAN(2024)33Level 2early September 2024PDF ↗
11 Jun 2024Clomethiazole 192mg capsulesMSAN(2024)32Level 2mid-July 2024PDF ↗
30 May 2024Somatropin (NutropinAq®) 10mg/2ml solution for injection cartridgesMSAN(2024)31Level 2Products have been discontinuedPDF ↗
30 May 2024Memantine (Valios®) 10mg and 20mg orodispersible tablets sugar freeMSAN(2024)30Level 2late August 2024PDF ↗
30 May 2024Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vialsMSAN(2024)29Level 2TBCPDF ↗
30 May 2024Clarithromycin 125mg/5ml and 250mg/5ml oral suspensionsMSAN(2024)28Level 2TBCPDF ↗
30 May 2024Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-freeMSAN(2024)27Level 2Products are being discontinuedPDF ↗
20 May 2024Humulin® S (insulin soluble human) 100units/ml solution for injection 10mlMSAN(2024)26Level 2mid-June 2024PDF ↗
17 May 2024Tegretol® (carbamazepine) 100mg/5ml liquidMSAN(2024)25Level 2TBCPDF ↗
13 May 2024Pancreatic enzyme replacement therapy (PERT)MSAN(2024)24Level 2Various resupply dates, please see belowPDF ↗
13 May 2024Humalog® (insulin lispro) 100units/ml solution for injection 10ml vialsMSAN(2024)23Level 2late May 2024PDF ↗
27 Apr 2024Mesalazine (Asacol®) 400mg MR gastro-resistant tabletsMSAN(2024)18Level 2discontinued - stock to be exhausted by late April 2024PDF ↗
25 Apr 2024Naloxegol (Moventig®) 12.5mg and 25mg tabletsMSAN(2024)17Level 2early August 2024PDF ↗
25 Apr 2024Carbamazepine 100mg and 200mg tabletsMSAN(2024)16Level 2mid-June 2024PDF ↗
25 Apr 2024Phenobarbital 15mg tablets (Accord)MSAN(2024)15Level 2TBCPDF ↗
28 Mar 2024Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension forMSAN(2024)10Level 2being discontinued, stock exhausted by the end of May 2024PDF ↗
19 Mar 2024Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-MSAN(2024)9Level 3end of 2024PDF ↗
15 Mar 2024Jext® 300micrograms/0.3ml (adrenaline 1 in 1000) solution for injection auto-MSAN(2024)8Level 2w/c 25 March 2024PDF ↗
08 Mar 2024Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials - UpdateMSAN(2024)7Level 2late June 2024PDF ↗
06 Mar 2024Lisdexamfetamine (Elvanse®) capsulesMSAN(2024)6Level 2April 2024PDF ↗
06 Mar 2024Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-MSAN(2024)5Level 2January 2025PDF ↗
29 Feb 2024Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vialsMSAN(2024)4Level 3TBCPDF ↗
29 Feb 2024Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringesMSAN(2024)3Level 2TBCPDF ↗
29 Feb 2024Epilim® (sodium valproate) syrup 200mg/5mlMSAN(2024)2Level 2w/c 22nd April 2024PDF ↗
12 Feb 2024Methadone 5mg tabletsMSAN(2024)1Level 2late May 2024PDF ↗
16 Oct 2023Azithromycin (Azyter®) 15mg/g eye drops (0.25g unit dose, preservative free)MSAN(2023)35Level 2mid-November 2023PDF ↗
16 Oct 2023Pancrease® HL gastro-resistant capsulesMSAN(2023)34Level 2discontinuation, stock to be exhausted by mid-November 2023PDF ↗
16 Oct 2023Bumetanide 1mg and 5mg tabletsMSAN(2023)33Level 3March 2024PDF ↗
06 Oct 2023Progesterone (Lutigest® ) 100mg vaginal tabletsMSAN(2023)32Level 2late December 2023PDF ↗
06 Oct 2023Hyoscine hydrobromide (Scopoderm®) 1.5mg patchesMSAN(2023)31Level 2until w/c 1st January 2024PDF ↗
04 Oct 2023Disopyramide (Rythmodan®)100mg capsulesMSAN(2023)30Level 2late October 2023PDF ↗
03 Oct 2023Azelaic acid (Skinoren®) 20% creamMSAN(2023)29Level 2early November 2023PDF ↗
29 Sep 2023Somatropin (Genotropin® MiniQuick) 1.4mg powder and solvent for solution forMSAN(2023)28Level 2w/c 1st January 2024PDF ↗
29 Sep 2023Midazolam (Epistatus®) 2.5mg/0.25mL and 10mg/1mL oromucosal solution pre-MSAN(2023)27Level 2late November 2023PDF ↗
29 Sep 2023Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution forMSAN(2023)26Level 2stock will be exhausted by w/c 18th December 2023PDF ↗
19 Sep 2023Estradiol (FemSeven®) 75micrograms/24hours and 100micrograms/24hoursMSAN(2023)25Level 2w/c 2nd October 2023PDF ↗
19 Sep 2023Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tabletsMSAN(2023)24Level 2w/c 11th December 2023PDF ↗
15 Sep 2023Permethrin 5% w/w creamMSAN(2023)23Level 2further noticePDF ↗
29 Aug 2023Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector penMSAN(2023)22Level 2w/c 11th September 2023PDF ↗
29 Aug 2023Phenytoin sodium 100mg capsules (Accord)MSAN(2023)21Level 3late December 2023PDF ↗
29 Aug 2023Pilocarpine hydrochloride 2% eye dropsMSAN(2023)20Level 2late September 2023PDF ↗
29 Aug 2023Minims® Povidone Iodine 5% w/v Eye Drops, SolutionMSAN(2023)19Level 3early October 2023PDF ↗
29 Aug 2023Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit doseMSAN(2023)18Level 3early October 2023PDF ↗
29 Aug 2023Estradiol (Estradot®) 25micrograms/24 hours, 37.5micrograms/24 hours andMSAN(2023)17Level 2late September 2023PDF ↗
22 Aug 2023Disulfiram 200mg tabletsMSAN(2023)16Level 2late August 2023PDF ↗
07 Aug 2023Tegretol® (carbamazepine) 100mg tabletsMSAN(2023)15Level 2end August 2023PDF ↗
07 Aug 2023Edronax® (reboxetine) 4mg tabletsMSAN(2023)14Level 2end of October 2023PDF ↗
25 Jul 2023Atomoxetine 40mg and 60mg capsulesMSAN(2023)13Level 2September 2023PDF ↗
12 Jul 2023GLP-1 receptor agonists used in the management of type 2 diabetesMSAN(2023)12Level 3mid-2024PDF ↗
09 Jun 2023Norditropin® Flexpro® and NordiFlex® (somatropin) solution for injection pre-MSAN(2023)11Level 2September 2023PDF ↗
09 Jun 2023Micronised Progesterone (Utrogestan®) 100mg capsulesMSAN(2023)10Level 2end of 2023PDF ↗
09 Jun 2023Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filledMSAN(2023)9Level 2January 2024PDF ↗
09 Jun 2023Glucagon 1mg powder for injection kit (GlucaGen®)MSAN(2023)8Level 2mid- July 2023PDF ↗
09 Jun 2023Ethinylestradiol 20microgram / Drospirenone 3mg (Eloine®) tabletsMSAN(2023)7Level 2late August 2023PDF ↗
09 Jun 2023Bromfenac (Yellox®) 900 micrograms/ml eye dropsMSAN(2023)6Level 2w/c 3 July 2023PDF ↗
25 Jan 2023• Insulin isophane biphasic human 25/75 (Insuman® Comb 25) 100units/mlMSAN(2023)4Level 2discontinuation, stock to be exhausted by May 2023PDF ↗
24 Jan 2023Vigabatrin (Sabril®) 500mg tabletsMSAN(2023)5Level 2w/c 3rd of March 2023PDF ↗
16 Jan 2023Sulfasalazine 250mg in 5ml oral suspension sugar freeMSAN(2023)3Level 2until early June 2023PDF ↗
16 Jan 2023Dalteparin (Fragmin®) 10,000units/1mL solution for injection ampouleMSAN(2023)2Level 3discontinuation - stock to be exhausted by May 2023PDF ↗
16 Jan 2023Selegiline (Eldepryl®) 5mg and 10mg tabletsMSAN(2023)1Level 2until April 2023PDF ↗
30 Dec 2022Antibiotics for the treatment of Group A Strep - UpdateMSAN(2022)7Level 3TBCPDF ↗
14 Dec 2022Antibiotics for the treatment of Group A StrepMSAN(2022)6Level 2TBCPDF ↗
04 Nov 2022NovoRapid FlexPen® (Insulin aspart) 100units/ml solution for injection 3ml pre-MSAN(2022)5Level 321 November 2022PDF ↗
29 Jul 2022Promethazine hydrochloride 25mg tabletsMSAN(2022)4Level 2until Mid-August 2022PDF ↗
29 Jul 2022Hydrocortisone 2.5mg Muco-Adhesive Buccal TabletsMSAN(2022)3Level 2w/c 5th September 2022PDF ↗
19 Jul 2022Alendronic acid 70mg tabletsMSAN(2022)2Level 2late-August 2022.PDF ↗
19 Jul 2022Paroxetine (Seroxat®) 20mg/10ml oral suspensionMSAN(2022)1Level 2to be discontinued in July 2022PDF ↗
09 Nov 2021Tocilizumab (RoActemra®) 162mg/0.9ml solution for injection pre-filledMSAN(2021)34Level 3January 2022PDF ↗
09 Nov 2021Champix® (varenicline) 0.5mg and 1mg tabletsMSAN(2021)33Level 3further noticePDF ↗
08 Nov 2021Latanoprost 50microgram/ml / timolol 5mg/ml (Fixapost®) 0.2ml unit doseMSAN(2021)32Level 2Mid November 2021PDF ↗
08 Nov 2021Acebutolol (Sectral®) 100mg capsulesMSAN(2021)31Level 2discontinued, stock expected to be exhausted by the end ofPDF ↗
06 Aug 2021Dalacin® (clindamycin) 2% vaginal creamMSAN(2021)30Level 2w/c 6th September 2021PDF ↗
06 Aug 2021Kolanticon gel® (2.5mg dicycloverine hydrochloride, 200mg aluminiumMSAN(2021)29Level 2January 2022PDF ↗
06 Aug 2021Tuberculosis (TB) oral agentsMSAN(2021)28Level 2See tablePDF ↗
06 Aug 2021Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35 ml and 4,500 units in 0.45MSAN(2021)27Level 3January 2022PDF ↗
06 Aug 2021Glipizide (Minodiab®) 5mg tabletsMSAN(2021)26Level 3mid-October 2021PDF ↗
03 Aug 2021Clexane® (enoxaparin) pre-filled syringesMSAN(2021)25Level 2November 2021PDF ↗
03 Aug 2021Nexium® (esomeprazole) 10mg gastro-resistant granules sachetsMSAN(2021)24Level 2w/c 16th August 2021PDF ↗
03 Aug 2021Catapres® (clonidine) 100microgram tabletsMSAN(2021)23Level 2w/c 4th October 2021PDF ↗
03 Aug 2021Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear dropsMSAN(2021)22Level 2April 2022PDF ↗
03 Aug 2021Gentisone HC® (Gentamicin 0.3% w/v and Hydrocortisone acetate 1% w/v) EarMSAN(2021)21Level 2w/c 25th October 2021PDF ↗
22 Apr 2021Pioglitazone 15mg/metformin 850mg (Competact®) tabletsMSAN(2021)20Level 2early May 2021PDF ↗
15 Apr 2021Chloral Hydrate 143.3mg in 5ml oral solutionMSAN(2021)19Level 2September 2021PDF ↗
15 Apr 2021Diamorphine hydrochloride powder for reconstitution and injection 5mg andMSAN(2021)18Level 2w/c 19th April 2021PDF ↗
15 Apr 2021Voriconazole (VFEND®) 40mg/ml powder for oral suspensionMSAN(2021)17Level 2late April 2021PDF ↗
15 Apr 2021Rifinah® 300mg/150mg (rifampicin 300mg/isoniazid 150mg) tabletsMSAN(2021)16Level 2late April 2021PDF ↗
31 Mar 2021H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2021)15Level 2various datesPDF ↗
31 Mar 2021Oral Contraceptive tablets (various brands)MSAN(2021)14Level 2Various dates - see tablePDF ↗
23 Mar 2021Irbesartan/hydrochlorothiazide 150mg/12.5mg tabletsMSAN(2021)13Level 2early May 2021PDF ↗
23 Mar 2021Enalapril 5mg tabletsMSAN(2021)12Level 2end of April 2021PDF ↗
16 Mar 2021Repaglinide 1mg and 2mg tabletsMSAN(2021)11Level 3early May 2021PDF ↗
08 Mar 2021Desmopressin (Octim®) 150 micrograms per actuation nasal spray (FerringMSAN(2021)10Level 2Q3 of 2023 - update to MSAN(2020)95PDF ↗
08 Mar 2021Sancuso® (granisetron) 3.1mg/24 hours transdermalMSAN(2021)7Level 2until late March 2021PDF ↗
08 Mar 2021Colestid® (colestipol) orange and plain 5g granules sachetsMSAN(2021)6Level 2end of May 2021PDF ↗
05 Mar 2021Morphine sulphate (MST CONTINUS®) 20mg, 30mg, 60mg, 100mg and 200mgMSAN(2021)5Level 3being discontinuedPDF ↗
02 Mar 2021Midazolam 10mg/2ml solution for injection ampoulesMSAN(2021)4Level 2until April 2021PDF ↗
02 Mar 2021Acetazolamide SR 250mg capsulesMSAN(2021)3Level 2until May 2021PDF ↗
02 Mar 2021Fluoxetine 40mg capsulesMSAN(2021)2Level 2end of March 2021PDF ↗
23 Feb 2021Phyllocontin® (Aminophylline) 225mg and 350mg modified release tabletsMSAN(2021)1Level 3being discontinued, supplies are to be exhausted by 5th April 2021PDF ↗
29 Dec 2020Docusate sodium 100mg capsulesMSAN(2020)119Level 2April 2021PDF ↗
29 Dec 2020Butec® (buprenorphine) 15microgram/hour transdermal patches (7-day)MSAN(2020)118Level 2w/c 18 January 2021PDF ↗
29 Dec 2020Dulcolax® (bisacodyl) 5mg and 10mg suppositoriesMSAN(2020)117Level 2various, see table belowPDF ↗
29 Dec 2020Rifadin® (rifampicin) 100mg/5ml oral suspensionMSAN(2020)116Level 2w/c 18 January 2021PDF ↗
29 Dec 2020Zemtard® (diltiazem) 240mg XL capsulesMSAN(2020)115Level 2w/c 1 February 2021PDF ↗
29 Dec 2020Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoulesMSAN(2020)114Level 2until late January 2021PDF ↗
17 Nov 2020Nalcrom® (sodium cromoglicate) 100mg capsulesMSAN(2020)113Level 2early January 2021PDF ↗
17 Nov 2020Trifluoperazine 1mg/5ml syrup (Advanz Pharma)MSAN(2020)112Level 2April 2021PDF ↗
17 Nov 2020Dulcolax® (bisacodyl) 5mg and 10mg suppositoriesMSAN(2020)111Level 2various, see table belowPDF ↗
09 Nov 2020Haloperidol 5mg/5ml oral solution sugar free (Thame Laboratories)MSAN(2020)110Level 2March 2021PDF ↗
09 Nov 2020Nalcrom® (sodium cromoglicate) 100mg capsulesMSAN(2020)109Level 2late November 2020PDF ↗
09 Nov 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)108Level 2Various datesPDF ↗
09 Nov 2020Zonisamide capsules various strengths (Glenmark and Teva)MSAN(2020)107Level 2mid-February 2021PDF ↗
09 Nov 2020Prednisolone 5mg Suppositories (RPH Pharmaceuticals)MSAN(2020)106Level 2January 2021PDF ↗
23 Oct 2020Salazopyrin En-Tabs® (sulfasalazine) 500mg tabletsMSAN(2020)105Level 1early December 2020PDF ↗
23 Oct 2020Fluoxetine 30mg capsules (Advanz)MSAN(2020)104Level 2mid-December 2020PDF ↗
23 Oct 2020Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tabletsMSAN(2020)103Level 2late November 2020PDF ↗
21 Oct 2020Dulcolax® (bisacodyl) 5mg suppositoriesMSAN(2020)102Level 2early December 2020PDF ↗
21 Oct 2020DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solutionMSAN(2020)101Level 2mid-2021PDF ↗
15 Oct 2020Lithium carbonate (Priadel®) 200mg and 400mg modified release tabletsMSAN(2020)100Level 3further noticePDF ↗
09 Oct 2020Sterculia (Normacol®) 62% w/w granulesMSAN(2020)99Level 2late October 2020PDF ↗
09 Oct 2020Oral Contraceptive tablets (various brands)MSAN(2020)98Level 2Various – see tablePDF ↗
09 Oct 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)97Level 2Various datesPDF ↗
09 Oct 2020Lorazepam (Ativan®) 4mg/ml Solution for injection (Pfizer)MSAN(2020)96Level 2Early December 2020PDF ↗
09 Oct 2020Desmopressin (Octim®) 150 micrograms per actuation nasal spray (FerringMSAN(2020)95Level 2mid-2021PDF ↗
29 Sep 2020Tuberculosis (TB) oral agentsMSAN(2020)94Level 2Various - please see table belowPDF ↗
29 Sep 2020Sterculia (Normacol®) 62% w/w granulesMSAN(2020)93Level 2Early October 2020PDF ↗
29 Sep 2020Enalapril 20mg tablets (various suppliers)MSAN(2020)92Level 2Mid-end October 2020PDF ↗
29 Sep 2020Metronidazole (Acea®) 0.75% gel (Ferndale Pharmaceuticals)MSAN(2020)91Level 2January 2021PDF ↗
29 Sep 2020Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml NebulesMSAN(2020)90Level 2Mid-February 2021PDF ↗
29 Sep 2020Zonisamide 50mg and 100mg Capsules (Teva)MSAN(2020)89Level 2Late November 2020PDF ↗
03 Sep 2020Lithium carbonate (Priadel®) 200mg and 400mg modified release tabletsMSAN(2020)88Level 3To be discontinued, supplies are expected to be exhausted by AprilPDF ↗
28 Aug 2020Sterculia (Normacol®) 62% w/w granulesMSAN(2020)87Level 213 SeptemberPDF ↗
27 Aug 2020Esomeprazole 40mg iv powder for solution (Grunenthal, Ranbaxy, Tillomed)MSAN(2020)86Level 2Early 2021PDF ↗
26 Aug 2020Lodoxamide 0.1% (Alomide®) eye dropsMSAN(2020)85Level 2TBCPDF ↗
26 Aug 2020Nabumetone 500mg TabletsMSAN(2020)84Level 2Early November 2020PDF ↗
26 Aug 2020Prednisolone 5mg Suppositories (RPH Pharmaceuticals)MSAN(2020)83Level 2Early November 2020PDF ↗
26 Aug 2020Diazepam (Diazemuls®) 10mg/2ml emulsion for injectionMSAN(2020)82Level 2February 2021PDF ↗
26 Aug 2020Oral Contraceptive tablets (various brands)MSAN(2020)81Level 2Various – see tablePDF ↗
26 Aug 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)80Level 2Various datesPDF ↗
11 Aug 2020Sulfasalazine 250mg/5mL oral suspension (Rosemont)MSAN(2020)79Level 2End September 2020 - update to MSAN (2020)31PDF ↗
11 Aug 2020Pethidine 50mg tabletsMSAN(2020)78Level 2TBCPDF ↗
05 Aug 2020Tuberculosis (TB) oral agentsMSAN(2020)77Level 2VariousPDF ↗
05 Aug 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)76Level 2Various datesPDF ↗
05 Aug 2020Senna with ispaghula husk (Manevac®) granules (Mylan)MSAN(2020)75Level 2February 2021PDF ↗
05 Aug 2020Nabumetone 500mg TabletsMSAN(2020)74Level 21st September 2020PDF ↗
27 Jul 2020Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml NebulesMSAN(2020)73Level 2Mid-December 2020PDF ↗
27 Jul 2020Enalapril 20mg tablets (various suppliers)MSAN(2020)72Level 2Early August 2020PDF ↗
23 Jul 2020Metronidazole (Acea®) 0.75% gel (Ferndale Pharmaceuticals)MSAN(2020)71Level 2September 2020PDF ↗
23 Jul 2020Ketotifen 1mg/5ml elixir (Zaditen®)MSAN(2020)70Level 2TBCPDF ↗
23 Jul 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)69Level 2Various datesPDF ↗
23 Jul 2020Oral Contraceptive tablets (various brands)MSAN(2020)68Level 2Various – see tablePDF ↗
23 Jul 2020Hormone Replacement Therapy (all formulations)MSAN(2020)67Level 3See table at Annex APDF ↗
13 Jul 2020Sodium cromoglicate (Intal®) CFC-free 5mg inhaler (Sanofi)MSAN(2020)66Level 2mid-November 2020PDF ↗
13 Jul 2020Ferrous Fumarate 322mg/Folic Acid 350microgram (Pregaday®) tabletsMSAN(2020)65Level 2October 2020PDF ↗
30 Jun 2020Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml NebulesMSAN(2020)64Level 24 November 2020PDF ↗
29 Jun 2020Phenelzine (Nardil) 15mg tabletsMSAN(2020)63Level 3No confirmed resupply datePDF ↗
29 Jun 2020Prednisolone 5mg Suppositories (RPH Pharmaceuticals)MSAN(2020)62Level 2End August 2020PDF ↗
29 Jun 2020Promazine 25mg and 50mg tabletsMSAN(2020)61Level 2w/c 29 June 2020PDF ↗
29 Jun 2020Phenytoin sodium NRIM 100mg capsulesMSAN(2020)60Level 3to be confirmedPDF ↗
29 Jun 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)59Level 2various, see belowPDF ↗
26 Jun 2020Lacosamide (Vimpat®) 50mg tablets (UCB Pharma Ltd)MSAN(2020)58Level 2w/c 20 July 2020PDF ↗
26 Jun 2020Mirtazapine 15mg and 45mg orodispersible tabletsMSAN(2020)57Level 2Late July 2020PDF ↗
25 Jun 2020Lodoxamide 0.1% (Alomide®) eye dropsMSAN(2020)56Level 224 August 2020PDF ↗
25 Jun 2020Imipramine 25mg tabletsMSAN(2020)55Level 2Early August 2020PDF ↗
23 Jun 2020Ranitidine: all formulationsMSAN(2020)54Level 2VariousPDF ↗
18 Jun 2020Tuberculosis (TB) oral agentsMSAN(2020)53Level 2VariousPDF ↗
18 Jun 2020Levodopa/carbidopa/entacapone tablets - various brands and strengthsMSAN(2020)52Level 2Early August 2020PDF ↗
11 Jun 2020Prednisolone 5mg Suppositories (RPH Pharmaceuticals)MSAN(2020)51Level 2End July 2020PDF ↗
01 Jun 2020Salazopyrin® (sulfasalazine) 500mg suppositoriesMSAN(2020)50Level 3w/c 15 June 2020PDF ↗
01 Jun 2020Promazine 25mg and 50mg tabletsMSAN(2020)49Level 2mid June 2020PDF ↗
01 Jun 2020Valproate semisodium (Depakote®) 250mg and 500mg tabletsMSAN(2020)48Level 2early July 2020PDF ↗
01 Jun 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)47Level 2various, see belowPDF ↗
01 Jun 2020Fluoxetine 40mg capsulesMSAN(2020)46Level 2TBCPDF ↗
01 Jun 2020Zyban® (bupropion hydrochloride) 150mg prolonged release tabletsMSAN(2020)45Level 3End November 2020PDF ↗
01 Jun 2020Danazol 100mg & 200mg capsulesMSAN(2020)44Level 3n/a – action to be taken as soon as possiblePDF ↗
27 May 2020Ranitidine: all formulationsMSAN(2020)43Level 2VariousPDF ↗
20 May 2020Tuberculosis (TB) oral agentsMSAN(2020)41Level 2VariousPDF ↗
18 May 2020Cycloserine 250mg capsulesMSAN(2020)42Level 2TBCPDF ↗
14 May 2020Salazopyrin® (sulfasalazine) 500mg suppositoriesMSAN(2020)40Level 35 June 2020PDF ↗
07 May 2020Ranitidine: all formulationsMSAN(2020)39Level 2VariousPDF ↗
01 May 2020Promazine 25mg and 50mg tabletsMSAN(2020)38Level 2Late May 2020PDF ↗
01 May 2020Valproate semisodium (Depakote®) 250mg and 500mg tabletsMSAN(2020)37Level 2mid May 2020PDF ↗
01 May 2020Convulex® (Valproic acid) 150mg, 300mg and 500mg capsulesMSAN(2020)36Level 3End May 2020PDF ↗
01 May 2020Disopyramide 150mg capsulesMSAN(2020)34Level 2Early May 2020PDF ↗
01 May 2020Ativan® (lorazepam) 4mg/mL Solution for injectionMSAN(2020)30Level 319 June 2020PDF ↗
30 Apr 2020H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2020)35Level 2various, see belowPDF ↗
30 Apr 2020Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2020)23MSAN(2020)33End July 2020PDF ↗
30 Apr 2020Propantheline bromide (Pro-Banthine) 15mg tablets (Kyowa Kirin)MSAN(2020)32Level 2End May 2020PDF ↗
30 Apr 2020Sulfasalazine 250mg/5mL oral suspension (Rosemont)MSAN(2020)31Level 2End August 2020PDF ↗
23 Apr 2020H2-antagonists (cimetidine, famotidine and nizatidine) – update to MSANMSAN(2020)25various, see belowPDF ↗
20 Apr 2020Acetazolamide SR 250mg capsulesMSAN(2020)28Level 2End July 2020PDF ↗
16 Apr 2020Penicillamine 125mg and 250mg tabletsMSAN(2020)27Late April 2020PDF ↗
16 Apr 2020Minims cyclopentolate hydrochloride 0.5% and 1%, eye drops solutionMSAN(2020)26early April 2020PDF ↗
16 Apr 2020DISOPYRAMIDE 150mg TABLETSMSAN(2020)24Late April 2020PDF ↗
16 Apr 2020Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2019)12MSAN(2020)23End July 2020PDF ↗
14 Apr 2020Diazepam (Diazemuls®) 10mg/2ml emulsion for injectionMSAN(2020)22Level 2expected September 2020PDF ↗
09 Apr 2020Cycloserine 250mg capsulesMSAN(2020)20Level 2TBCPDF ↗
02 Apr 2020Stanek® (levodopa/carbidopa/entacapone) tablets - various strengthMSAN(2020)21Level 2various – see table belowPDF ↗
16 Mar 2020Phenelzine (Nardil) 15mg tabletsMSAN(2020)19No confirmed resupply datePDF ↗
16 Mar 2020Fluoxetine 10mg tabletsMSAN(2020)16Level 2late 2020PDF ↗
16 Mar 2020Promazine 25mg and 50mg tabletsMSAN(2020)15Level 2Mid-April 2020PDF ↗
13 Mar 2020Clonidine 25 microgram tabletsMSAN(2020)18End April 2020PDF ↗
13 Mar 2020Lorazepam (Ativan®) 4mg/mL injectionMSAN(2020)17w/c 23rd March 2020PDF ↗
12 Mar 2020Salofalk® (mesalazine) 500mg and 1g suppositories – update to MSAN (2019)12MSAN(2020)14Level 2mid-September 2020PDF ↗
12 Mar 2020Valproate semisodium (Depakote®) 250mg and 500mg tabletsMSAN(2020)13Level 2Early April 2020PDF ↗
08 Mar 2020Docusate sodium 100mg capsulesMSAN(2021)9Level 2June 2021 - update MSAN(2020)119PDF ↗
08 Mar 2020Fluoxetine 10mg tabletsMSAN(2021)8Level 2September 2021 - update to MSAN(2020)16PDF ↗
06 Mar 2020Salbutamol 2mg/5mL syrup – update to MSAN (2020)5MSAN(2020)12Level 2end March 2020PDF ↗
06 Mar 2020H2-antagonists (cimetidine, famotidine and nizatidine) – update toMSAN(2020)11Level 2various, see belowPDF ↗
27 Feb 2020Diamorphine Hydrochloride powder for reconstitution and injection 5mg &MSAN(2020)10Level 3Spring / Summer 2020PDF ↗
26 Feb 2020Epanutin® (phenytoin) 30mg/5mL Oral SuspensionMSAN(2020)9Level 319 June 2020PDF ↗
21 Feb 2020Lorazepam (Ativan®) 4mg/mL injectionMSAN(2020)8Level 2w/c 16th March 2020PDF ↗
21 Feb 2020Penicillamine 125mg and 250mg tabletsMSAN(2020)7Level 2Late March 2020PDF ↗
14 Feb 2020Levomepromazine 25mg/1mL solution for injectionMSAN(2020)6Level 2w/c 24 February 2020PDF ↗
12 Feb 2020Salbutamol 2mg/5mL syrupMSAN(2020)5Level 2end February 2020PDF ↗
29 Jan 2020Tuberculosis (TB) oral agentsMSAN(2020)4Level 2see supporting information at annex APDF ↗
21 Jan 2020Hormone Replacement Therapy (all formulations)MSAN(2020)3See table at Annex APDF ↗
17 Jan 2020Azathioprine 25mg tabletsMSAN(2020)2Level 2w/c 27 January 2020PDF ↗
10 Jan 2020Phenytoin sodium NRIM 100mg capsulesMSAN(2020)1Level 38 May 2020PDF ↗
24 Dec 2019Convulex® (Valproic acid) 150mg, 300mg and 500mg capsulesMSAN(2019)31Level 330 April 2020PDF ↗
23 Dec 2019Minims cyclopentolate hydrochloride 0.5% and 1%, eye drops solutionMSAN(2019)30Level 2early January 2020PDF ↗
23 Dec 2019H2-antagonists (cimetidine, famotidine and nizatidine)MSAN(2019)29Level 2various, see belowPDF ↗
23 Dec 2019Clonidine 25 microgram tabletsMSAN(2019)28Level 2mid-January 2020PDF ↗
18 Dec 2019Haloperidol (Serenace®) 500 microgram capsules (Teva)MSAN(2019)27Level 2Date to be determinedPDF ↗
09 Dec 2019Benzylpenicillin sodium 1200mg and 600mg powder for injectionMSAN(2019)26Level 216 December 2019PDF ↗
09 Dec 2019Midazolam (5mg/ml) 50mg in10ml solution for injection ampoulesMSAN(2019)25Level 231 January 2020PDF ↗
02 Dec 2019Emerade® 150 microgram, 300 microgram and 500 microgram adrenaline auto-MSAN(2019)24Level 331 January 2020PDF ↗
28 Nov 2019Slo-phyllin® (Theophylline) 60mg/125mg/250mg capsulesMSAN(2019)23Level 328 February 2020PDF ↗
28 Nov 2019RANITIDINE ALL FORMULATIONSMSAN(2019)2228 February 2020PDF ↗
22 Nov 2019Fluorouracil 5% (Efudix®) creamMSAN(2019)21Level 2w/c 16 December 2019PDF ↗
22 Nov 2019Reboxetine (Edronax®) 4mg tabletsMSAN(2019)20Level 2w/c 16 December 2019PDF ↗
20 Nov 2019Tuberculosis (TB) oral agentsMSAN(2019)19Level 21see supporting information at annex APDF ↗
15 Nov 2019DISOPYRAMIDE 150mg TABLETSMSAN(2019)17Level 2113 December 2019PDF ↗
15 Nov 2019PROVERA® (MEDROXYPROGESTERONE ACETATE) 100mg AND 200mgMSAN(2019)16Level 21OngoingPDF ↗
15 Nov 2019PETHIDINE 50MG TABLETSMSAN(2019)15Level 21early to mid-December 2019PDF ↗
15 Nov 2019SYNPHASE® (ETHINYLESTRADIOL AND NORETHISTERONE) TABLETSMSAN(2019)14Level 2120 December 2019PDF ↗
08 Nov 2019Medicine in short supply: Procyclidine solution for injection amp 10mg/2mlMSAN(2019)13Level 2March 2020PDF ↗
01 Nov 2019______________________MSAN(2019)12Level 2week commencing 16 December 2019 NetworkPDF ↗
01 Nov 2019Community Pharmacy ScotlandMSAN(2019)11Level 2mid-November 2019PDF ↗
01 Nov 2019Addressees:MSAN(2019)10Ongoing Medicines Shortage ResponsePDF ↗
28 Oct 2019Medicine in short supply: Seroxat® (paroxetine) 20mg/10ml For actionMSAN(2019)9Level 2January 2020 NetworkPDF ↗
28 Oct 2019Medicine in short supply: Ongentys® (opicapone) 50mg For actionMSAN(2019)8Level 3Mid-January 2020 PharmacistsPDF ↗
25 Oct 2019Addressees:MSAN(2019)7Level 3October 2020 NetworkPDF ↗
16 Oct 2019______________________MSAN(2019)6Level 315 January 2020 NHS Medical DirectorsPDF ↗
11 Oct 2019MEDICINE / DRUG IN SHORT SUPPLY: Detrusitol XL For actionMSAN(2019)5Level 26 December 2019 NetworkPDF ↗
11 Oct 2019Medicine/Drug in short supply: Nardil (phenelzine sulfate) For actionMSAN(2019)4Level 2March 2020 NetworkPDF ↗
23 Sep 2019MEDICINE / DRUG IN SHORT SUPPLY: PROVERA® For actionMSAN(2019)2Level 28 November 2019 PharmacistsPDF ↗
23 Sep 2019MEDICINE / DRUG IN SHORT SUPPLY: FLUOXETINE 10MG, For actionMSAN(2019)1Level 2October – December 2019 (detail below) PharmacistsPDF ↗
21st January 2025MSAN(2025)421 February 2025PDF ↗
Medicine in short supply: Minims phenylephrine 2.5% and 10% w/v eye dropsMSAN(2019)18Level 3January 2020PDF ↗
Medicine/Drug in short supply: Adrenalin auto-injectorsMSAN(2019)3Ongoing ______________________PDF ↗

Scotland coverage is additive and clearly separated — it is notmerged into the England register, medicine recurrence, or the UK Shortage Index, which remain England-first per the methodology. Dates and “valid until” text are as stated in the source PDFs; fuzzy wording is kept as written. Not an official NHS service.